Raffles Medical Group Ltd (SGX:BSL)

Market Cap	1.55B -15.9%
Revenue (ttm)	740.31M -3.3%
Net Income	67.48M +5.9%
EPS	0.04 +6.4%
Shares Out	1.83B
PE Ratio	23.14
Forward PE	24.93
Dividend	0.03 (3.55%)
Ex-Dividend Date	May 12, 2026

Volume	4,706,200
Open	0.8350
Previous Close	0.8400
Day's Range	0.8350 - 0.8500
52-Week Range	0.8050 - 1.0800
Beta	0.24
Analysts	Buy
Price Target	1.05 (+24.26%)
Est. Earnings	Nov 10, 2026

About Raffles Medical Group

Raffles Medical Group Ltd provides private healthcare services in Singapore, Greater China, Vietnam, Cambodia, and Japan. It operates through four segments: Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services. The company operates Raffles Hospital that offers 24-hour acute and critical care; ambulance services and mobile medical calls to home, hotels, worksites, and onboard ships; and triage, emergency consultation, and inpatient ward admission services. Its hospital also provides various services, including covi...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1976
• Employees: 2,900
• Stock Exchange: Singapore Exchange
• Ticker Symbol: BSL

Financial Performance

In 2025, Raffles Medical Group's revenue was 765.57 million, an increase of 1.75% compared to the previous year's 752.43 million. Earnings were 70.57 million, an increase of 13.38%.

Analyst Summary

According to 7 analysts, the average rating for BSL stock is "Buy." The 12-month stock price target is $1.05, which is an increase of 24.26% from the latest price.

Price Target

$1.05

(24.26% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error